Suppliers / Curia Spain S.A.U

Curia Spain S.A.U

France 3 duplicate records merged Updated 9 July 2026

Curia Spain S.A.U is an API manufacturer based in France. It holds 41 active US drug master files and 8 valid CEPs. Its filings concentrate with MINSA (CR) and NCELS (KZ). Its GMP standing is certified by ANSM (FR), MFDS (Korea) and AEMPS (ES). Its most recent recorded inspection, by US FDA, closed on 27 February 2023 as VAI.

41
active US DMFs
8
valid CEPs
10
registered plants 1 with an FDA FEI number
8
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 27 February 2023 VAI US FDA
  • 12 March 2020 VAI US FDA
  • 28 May 2018 NAI US FDA
  • 21 October 2016 VAI US FDA
  • 21 March 2014 VAI US FDA
  • 23 June 2011 NAI US FDA
  • 17 June 2011 NAI US FDA
  • 27 October 2008 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Valladolid, Spain Not on file
Spain, Spain 3002996872
Bon-Encontre, France Not on file
TONNEINS, France Not on file
BON ENCONTRE, France Not on file
Tonneins, France Not on file

4 further sites are on record.

What they file, and where

Molecule Regulators Docs
Hydrocortisone US FDA 3
Betamethasone US FDA 2
Budesonide US FDA 2
Dorzolamide SFDA (Saudi Arabia), US FDA 2
Methylprednisolone US FDA 2
Olopatadine US FDA 2
Alcaftadine US FDA 1
Alclometasone US FDA 1
Altrenogest US FDA 1
Betamethasone Dipropionate SFDA (Saudi Arabia) 1
Show all 30 molecules on file
Brexanolone US FDA 1
Carbimazole EDQM 1
Chlortalidone EDQM 1
Clobetasol Propionate US FDA 1
Deoxycholic Acid US FDA 1
Deucravacitinib US FDA 1
Dexamethasone US FDA 1
Diethylamine Salicylate SFDA (Saudi Arabia) 1
Etonogestrel US FDA 1
Exemestane US FDA 1
Fludrocortisone US FDA 1
Fluorometholone US FDA 1
Flutamide EDQM 1
Fluticasone Propionate US FDA 1
Ganaxolone US FDA 1
Hexetidine EDQM 1
Hydrocortisone Butyrate US FDA 1
Loteprednol Etabonate US FDA 1
Medroxyprogesterone Acetate US FDA 1
Mifepristone US FDA 1

Also appears on these molecule pages

Show 5 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 7 None
NCELS (KZ) 1 None
ANSM (FR) None 40
MFDS (Korea) None 2
AEMPS (ES) None 2

Comparing suppliers?

Choose your molecules and target markets. Curia Spain S.A.U comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 2 active litigation matters are on record.
  • The most recent inspection outcome was VAI, on 27 February 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates